中文 | ENG

第58卷 第3期 2025-5
Elevating the standards of scientific editing in clinical surgery: Learning from editorial and journal role models

.........................

第58卷 第3期 2025-5
Improving online physician evaluations for surgeons using sentiment analysis and alternative perspectives

.........................

第58卷 第3期 2025-5
Ensuring ethical and qualified authorship: The key to trustworthiness in clinical surgery journal

.........................

第58卷 第3期 2025-5
Artificial intelligence for academic purpose in clinic surgery: ChatGPT, Turnitin, and false positive

.........................

第58卷 第3期 2025-5
COVID-19, COVID-19 vaccination, risk of cardiac myxoma in view of clinical surgery

.........................

第58卷 第3期 2025-5
Eggplant deformity in penile fracture

.........................

第58卷 第3期 2025-5
Splenectomy for Klippel-Trenaunay syndrome: Systematic review and case series

.........................

第58卷 第3期 2025-5
Comments on “Risk factors for spinal cord injury without radiographic abnormality in trauma cases at a single trauma center”

.........................

第58卷 第3期 2025-5
Impact of fluorescence-guided surgery on splenic preservation: A case of splenic hydatidosis

.........................

第58卷 第3期 2025-5
Adult pancreatoblastoma presentingwith obstructive jaundice: A case report and literature review

.........................

第58卷 第3期 2025-5
Pilonidal disease management in young adults: A retrospective analysis of practices in a single tertiary center in Bahrain

.........................

第58卷 第3期 2025-5
Long-term comparative outcomes in patients undergoing transcatheter aortic valve implantation with self-expanding valves versus balloon-expandable valves: A retrospective observational study

.........................

第58卷 第3期 2025-5
Comparative study between the effectiveness of Amnion-CollaGee (Collagen-Gelatin-Elastin) as a biological product wound dressing and conventional dressing on the donor site of the split-thickness skin graft in animals model (rats)

.........................

第58卷 第3期 2025-5
Enhancing mortality Probability Model II predictive accuracy with the lethal triad in intensive care unit trauma patients: A retrospective study

.........................

第58卷 第3期 2025-5
Dr. Shao-Wei Chen's contribution to analysis of outcomes of patients undergoing cardiac surgery and aortic disease: Big data analytics

.........................

第58卷 第2期 2025-3
Predatory publisher and low standard journal: An emerging problem in clinical surgery field

.........................

第58卷 第2期 2025-3
Conflict of interest in clinical surgery: Contemporary concern in digital era

.........................

第58卷 第2期 2025-3
Postpublication redecision and pitfalls of inadequate standards in scientific surgical journals: Important consideration in academic publication

.........................

第58卷 第2期 2025-3
Spontaneous bilateral basal ganglia hemorrhage

.........................

第58卷 第2期 2025-3
Academic characterization of the Formosan Journal of Surgery: A five-year bibliometric analysis

.........................
登入帳號才能閱讀全文
 
篇名 Expression of Drug Resistance-Related Membranous Glycoprotein (gp-170) in Normal Kidney and Renal Cell Carcinoma Tissues
作者 Dah-Shyong Yu, Sun-Yran Chang, Cheng-Ping Ma
卷期/出版年月 30卷3期 (1997/6)
頁次 143-148
摘要 Renal cell carcinoma has been known for its drug resistance in clinical patients. The multidrug resistance gene (MDR1)-related glycoprotein, gp-170 in cancer cells, is one of the major causes of chemotherapeutic failure. To clarify the possible role of gp-170 in renal cell carcinoma, the expression of gp-170 was examined immunohistochemically using an antibody against gp-170 in normal kidney tissue and renal cancer. This study shows that 6 out of 20 (30%) normal kidney tissues had gp-170 expression while 9 out of 30 (30%) renal tumors had gp-170 staining. The gp-170 expression is not related to the tumor cell type or stage. The relatively low positive rate of gp-170 in renal cell carcinoma with a similar expression rate in normal kidney tissue suggests that there must be other mechanisms participating in the MDR of renal cancer.
關鍵詞 renal cell carcinoma, multidrug resistance, glycoprotein gp-170
分類 Original Article

台灣外科醫學會雜誌 © 2006 Taiwan Surgical Association All Rights Reserved
會 址:台北市南京東路五段 31 號 3 樓
電 話:(02) 2769-7845 傳 真:(02) 2746-7149 Email: journal@surgery.org.tw